A Conversation With Gillian Woollett, MA, DPhil, Senior Vice President, Avalere Health In the conclusion of a two-part conversation with one of the real go-to experts in the biosimilar field and US regulatory process, we talk with Dr. Woollett about the need for a new approach by the FDA when evaluating biosimilar applications. Biosimilars Review … Continue reading A More Useful Way of Evaluating New FDA Biosimilar Applications →